Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

Clinical trial NCT03399773 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03399773
Sponsor: Fred Hutchinson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Biphenotypic Leukemia Acute Lymphoblastic Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Hematopoietic and Lymphoid Cell Neoplasm Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts

Start date: 2022-05-10
Primary completion: 2025-06-09
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.